ACE inhibitors and statins are well tolerated in teenagers with Type 1 Diabetes but more evidence is required to demonstrate whether they are effective in preventing rapid increases in albumin excretion and associated complications leading to cardiovascular disease.
Read the limbic's , an editorially independent publication for healthcare professionals, interview with Children's Diabetes Centre co-director Professor Tim Jones, here.